Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Cerilliant
Dow
McKesson
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Healthtrust

Generated: June 25, 2018

DrugPatentWatch Database Preview

Biovail Company Profile

« Back to Dashboard

What is the competitive landscape for BIOVAIL, and what generic and branded alternatives to BIOVAIL drugs are available?

BIOVAIL has ten approved drugs.



Summary for Biovail
US Patents:0
Tradenames:8
Ingredients:6
NDAs:10
Patent Litigation for Biovail: See patent lawsuits for Biovail

Drugs and US Patents for Biovail

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail ISORDIL isosorbide dinitrate TABLET;SUBLINGUAL 012940-004 Jul 29, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up
Biovail ISORDIL isosorbide dinitrate TABLET;SUBLINGUAL 012940-005 Jul 29, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up
Biovail Labs Intl CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET, ORALLY DISINTEGRATING;ORAL 021763-002 Dec 20, 2005 DISCN No No ➤ Sign Up ➤ Sign Up
Biovail Labs Intl TOVALT ODT zolpidem tartrate TABLET, ORALLY DISINTEGRATING;ORAL 021412-002 Apr 25, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Biovail

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 4,472,380 ➤ Sign Up
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 4,880,631 ➤ Sign Up
Biovail CARDIZEM SR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019471-004 Jan 23, 1989 4,721,619 ➤ Sign Up
Biovail DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020939-004 Jan 28, 2000 5,288,505 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
Colorcon
Deloitte
Accenture
Merck
Dow
Julphar
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.